Breaking News

Ketamine bubble bursting, another rare gene protecting against Alzheimer's, & naloxone price meeting

May 16, 2023
Reporter, Morning Rounds Writer
Good morning. Today we have news on ketamine, a meeting to come on naloxone, and a protective gene variant against Alzheimer's.

mental Health

Ketamine clinics' ambitions run into harsh realities

KetamineClinicBubble_Illustration_MollyFerguson_051523

Molly Ferguson for STAT

For all the buzz around ketamine as a mental health treatment, keeping a business afloat based on it hasn't been a slam dunk. Clinics across the country have been shutting down, sunk by over-ambitious dreams to grow big from administering the longtime anesthetic newly popular as a treatment for serious depression. Safely providing ketamine infusions is time-consuming and expensive. Like psychedelic medications more broadly, they're typically combined with psychotherapy and require oversight by medical professionals, limiting the pool of potential patients. 

One former clinic director who declined to be named said he left the luxury chain Field Trip when it decided to offer cheaper, at-home treatment with only a "sitter" to monitor the patient. "The medicine is not expensive, the time is," said Sara Herman, an anesthesiologist and founder of a ketamine clinic in Menlo Park, Calif. "If someone is trying to make a bunch of money, I suggest looking elsewhere." STAT's Isabella Cueto and Olivia Goldhill have more.


exclusive

Biden drug czar to gather naloxone makers on pricing

Naloxone is widely viewed as a critical weapon in the battle against drug overdose deaths, but it's expensive. Now the White House is convening naloxone manufacturers to discuss the price of the medication used to reverse opioid overdoses. Narcan, a naloxone product that received over-the-counter approval in March, remains cost-prohibitive for many consumers, public health organizations, and harm-reduction groups. 

"We are going to be monitoring the price," Rahul Gupta, director of the White House Office of National Drug Control Policy, told STAT's Lev Facher. "We're going to do a roundtable because I want to make sure of exactly the concerns here." Emergent BioSolutions said recently that it would aim to price a two-pack of Narcan at under $50; Pfizer and other companies manufacture cheap, generic naloxone in injectable form; and another naloxone nasal spray manufactured by the nonprofit Harm Reduction Therapeutics is expected to receive over-the-counter approval from the FDA later this year. Read more.


environmental health

Study affirms link between contaminated water and Parkinson's

Back in 2017, the U.S. government agreed to pay disability benefits totaling more than $2 billion to veterans who had been exposed to contaminated drinking water while assigned to Camp Lejeune in North Carolina between 1953 and 1987. Eight diseases were covered, including several types of cancer and Parkinson's disease. Researchers writing in JAMA Neurology yesterday said the evidence for a link to Parkinson's was presumed, not proven, back then, so they conducted a new study comparing Marine veterans who lived at Camp Lejeune to those based at Camp Pendleton in California from 1975 to 1985.

Among the 340,000 Marines, the risk of Parkinson's was 70% higher at Camp Lejeune, where the water was contaminated with the solvent trichloroethylene, once used in dry cleaning and many home-cleaning products. The authors warn that "millions worldwide have been and continue to be exposed to this ubiquitous environmental contaminant."



Closer Look

Another rare genetic variant protects a second person from early Alzheimer'sCOLBOS_BrainImage

Justin Sanchez

The man belonged to an extended family in Colombia long followed by scientists for a particular mutation they share that destines them for early Alzheimer's disease. But he became the second person who appears to have been protected by another genetic variant. Instead of developing dementia in his 40s, he was cognitively healthy until his late 60s, dying at age 74. His genetic variant differed from the one in the first case, making the protective pathway appear wider.

In the new study out yesterday in Nature Medicine, scientists implicated a gene variant that seemed to slow the buildup of tau in the man's brain. Both tau and amyloid are implicated in Alzheimer's, and the family members have a mutation in a gene that causes the overproduction of the protein fragment beta-amyloid. STAT's Andrew Joseph has more on what this discovery could mean, including whether other mechanisms could be involved.


health inequities

Kids more likely to be 'undertriaged' in EDs if their caregivers speak a language other than English

In emergency medicine, triage is more than who should be seen first. It also asks what patients need, based on the acuity and severity of their condition. A new study in Pediatrics today reports that children whose caregivers requested languages other than English were more likely to be "undertriaged," assessed as needing less urgent attention than patients in similar circumstances with English-speaking caregivers. Examples of undertriaging are underestimating the need for hospital admission; for ED resources such as nebulized medication, IV placement, or supplemental oxygen; or for a return to the emergency department with admission within 14 days.

Among the 1 in 5 visits that involved caregivers preferring languages other than English at two emergency departments in Washington, D.C., undertriaging affected 3.7% of English speakers versus 4.6% of Spanish speakers and 5.9% if speakers of other languages. The researchers suggest known inequities in emergency health care may start with triage.


pandemic

On dropping masks in medical settings, a counterpoint says 'not yet'

We may be seeing fewer and fewer masks in public places now that the Covid public health emergency has ended, but that doesn't mean the controversy on universal masking in health care sites has ended. One month ago my colleague Helen Branswell told you eight infectious disease specialists called for dropping mask mandates, arguing in a commentary in Annals of Internal Medicine that Covid-19 should be handled the same way as other endemic respiratory pathogens — with standard infection control practices.

Yesterday the journal published a new commentary from two infectious disease experts countering that opinion, saying for patient safety, now is not the time to take off masks in health care venues: "Although gold-standard evidence is not available, we argue that, despite the lack of clinical efficacy trials (as with the widely accepted practice of hand hygiene), masking in interactions between patients and health care personnel should continue to receive serious consideration as a patient safety measure."


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

What we're reading

  • Federal appeals court freezes decision striking down free preventive health services, Axios
  • Biden nominates Monica Bertagnolli to head NIH, STAT
  • County with high rate of overdose deaths doesn't use opioid settlement funds for addiction program, CNN
  • Envision Healthcare files for bankruptcy, STAT
  • Families scramble to find growth hormone drug as shortage drags on, NPR


Thanks for reading! More tomorrow,


Enjoying Morning Rounds? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2023, All Rights Reserved.

No comments